BSEM READ THE FULL BSEM RESEARCH REPORT BioStem Technologies, Inc. (OTC:BSEM) is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, ...
A strong third-quarter performance in 2024 has raised expectations that the Employees Provident Fund (EPF) dividend rate could exceed 6 per cent this ...
DXY holds gains around 106.00 after Fed's Bullard comments. US CPI data showed inflation in October rising by 2.6%, in line with estimates. Core CPI rises by 3.3%, exceeding expec ...
Third quarter results highlight strong operational performance across key value drivers: YUPELRI® (revefenacin) net sales of $62.2 million, recognized by Viatris ...